SAN FRANCISCO, Nov. 6 – Nanogen completed internal validation of a DNA-based  research protocol for the MTHFR mutation to use on the NanoChip Molecular Biology Workstation, the company announced Tuesday.

MTHFR is associated with cardiovascular disease and the pathology of thrombosis. Protocol users will have the option to further develop and validate the protocols for internal use, the company said.

This is the fourth DNA-based research protocol that the San Diego-based company has internally validated for use on the NanoChip Molecular Biology Workstation.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.